ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.
Contents
- L02AA Estrogens
- L02AB Progestogens
- L02AE Gonadotropin releasing hormone analogues
- L02BA Anti estrogens
- L02BB Anti androgens
- L02BG Aromatase inhibitors
- L02BX Other hormone antagonists and related agents
- References
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L02AA Estrogens
L02AA01 DiethylstilbestrolL02AA02 Polyestradiol phosphateL02AA03 EthinylestradiolL02AA04 FosfestrolL02AB Progestogens
L02AB01 MegestrolL02AB02 MedroxyprogesteroneL02AB03 GestonoroneL02AE Gonadotropin-releasing hormone analogues
L02AE01 BuserelinL02AE02 LeuprorelinL02AE03 GoserelinL02AE04 TriptorelinL02AE05 HistrelinL02BA Anti-estrogens
L02BA01 TamoxifenL02BA02 ToremifeneL02BA03 FulvestrantL02BB Anti-androgens
L02BB01 FlutamideL02BB02 NilutamideL02BB03 BicalutamideL02BB04 EnzalutamideL02BG Aromatase inhibitors
L02BG01 AminogluthetimideL02BG02 FormestaneL02BG03 AnastrozoleL02BG04 LetrozoleL02BG05 VorozoleL02BG06 ExemestaneL02BX Other hormone antagonists and related agents
L02BX01 AbarelixL02BX02 DegarelixL02BX03 AbirateroneReferences
ATC code L02 Wikipedia(Text) CC BY-SA